Environmental Exposures, Genetics, and Exhaled Nitric Oxide in Pediatric Asthma

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

225 participants

Study Classification

OBSERVATIONAL

Study Start Date

2006-07-31

Study Completion Date

2008-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Asthma is one of the most common childhood diseases. It is chronic and often severely disabling. The amount of nitric oxide that is exhaled while breathing increases with airway inflammation, a symptom of asthma. This study will examine the results from a previous study, the Cincinnati Asthma Prevention (CAP) study, to evaluate the effects of environmental and genetic factors on exhaled nitric oxide (eNO) levels and to determine the relationship between eNO and asthma severity.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Exhaled Nitric Oxide and Airway Caliber in Children With Asthma

NCT01645397

Asthma in Children

COMPLETED

The Genetics of Severe Asthma in Children

NCT01238432

Asthma

COMPLETED

Asthma Severity in Children and Environmental Agents

NCT00042705

Asthma

COMPLETED

Pharmacogenetics Use For Further Treatment Improvement in childreN

NCT03654508

Asthma in Children

COMPLETED NA

Critical Windows in the Development of Asthma Endotypes and Phenotypes in High-Risk Toddlers

NCT05210361

Asthma in Children Wheezing

ACTIVE_NOT_RECRUITING

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Nitric oxide is a naturally occurring gas that plays a role in many body functions. Levels of eNO increase with airway inflammation, a symptom of asthma. Researchers have proposed using eNO as a noninvasive measure to guide physicians in the treatment and medical management of asthma in children. However, more information about eNO is needed before this can happen. This study will perform a secondary analysis of the results from its parent study, the CAP study, which evaluated the effectiveness of preventing asthma in children who had been exposed to environmental tobacco smoke.

This study will not enroll any new participants. Previously collected data from the CAP study will be reevaluated in this study to determine the longitudinal effects of environmental and genetic factors on eNO levels. In addition, the data will be evaluated to determine the relationship between eNO levels and asthma severity. No new data will be collected in this study.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Asthma

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Participated in the Cincinnati Asthma Prevention Study
* Diagnosis of asthma
* Lives with someone that smokes at least 5 cigarettes a day

Exclusion Criteria

* No additional neuromuscular or respiratory disorder that may interfere with safe participation in the parent study
* Does not have electricity
* Plans to move within 1 year of entry into the parent study

Minimum Eligible Age

6 Years

Maximum Eligible Age

12 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No